16/05/2020

Exvastat receives prestigious Innovative Medicines Initiative grant to fund clinical study of imatinib in the treatment of COVID-19-associated ARDS

Global Newswire: https://www.globenewswire.com/news-release/2020/05/15/2034015/0/en/Exvastat-receives-prestigious-Innovative-Medicines-Initiative-grant-to-fund-clinical-study-of-imatinib-in-the-treatment-of-COVID-19-associated-ARDS.html CAMBRIDGE, UK AND DUBLIN, IRELAND, May 13 2020 / / -- Exvastat (Ireland) Ltd, a privately held...
Read More
21/11/2017

Exvastat Begins Clinical Development Programme for Repurposed Product for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Exvastat Begins Clinical Development Programme for Repurposed Product for the Treatment of Acute Respiratory Distress Syndrome (ARDS) CAMBRIDGE UK, Nov...
Read More
20/02/2017

News